Efficiency of second-line BRAF/MEK inhibitors in BRAFV600 mutated metastatic melanoma patients after first-line immunotherapy failure: A EUMelaReg real-world study

Results

Naziv:	Efficiency of second-line BRAF/MEK inhibitors in BRAFV600 mutated metastatic melanoma patients after first-line immunotherapy failure: A EUMelaReg real-world study
Autori :	Ellebaek, E; ...; Dujovic, B; ...; (broj, koautora 20)
Godina:	2025
Publikacija:	ANNALS OF ONCOLOGY
ISSN:	0923-7534 Annals of Oncology Pretraži identifikator
Tip rezultata:	Konferencijski rad
Kolacija:	vol. 36 str. S976-S977
DOI:	10.1016/j.annonc.2025.08.2274
WoS-ID:	001634626200046
URI:	https://enauka.gov.rs/handle/123456789/1019102
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Altmetric

Dimensions

Unpaywall

Google Scholar^TM